Indian Journal of Health Sciences and Care
  • Year: 2021
  • Volume: 8
  • Issue: 3

Child with Isoniazid Induced Psychosis: A Case Report

  • Author:
  • Richa1,*, Bharti Yadav2, Sanasam Manimukta Singh2, Shikha Sadadiwala2, Shashi Sharma3, Antan George4
  • Total Page Count: 3
  • Page Number: 174 to 176

1Assistant Professor, Department of Pediatrics, SGT Medical College, Hospital and Research Institute, Gurugram, Haryana, India

2Postgraduate Student, Department of Pediatrics, SGT Medical College, Hospital and Research Institute, Gurugram, Haryana, India

3Professor, Department of Pediatrics, SGT Medical College, Hospital and Research Institute, Gurugram, Haryana, India

4Postgraduate Student, Department of Pediatrics, SGT Medical College, Hospital and Research Institute, Gurugram, Haryana, India

*Corresponding author email id: richa.s2507@gmail.com

Online published on 4 June, 2022.

Abstract

Isoniazid (INH) is first-line anti-tuberculosis drug and is routinely recommended as part of active and latent treatment of tuberculosis (TB) in all age groups. The adverse reactions of INH vary from mild hepatitis to severe neurological symptoms and psychosis. We report a case of drug-induced psychosis secondary to isoniazid intake in a twelve-year-old female child, who developed paranoid features after the sixth day of Isoniazid. There was no previous history of such behaviour. The child was developmentally normal and had a good scholastic performance. No history of substance abuse and no significant family history of similar illness could be elicited. All Anti tubercular drugs (ATT) were stopped and she was started on risperidone and clonazepam for management of psychotic symptoms. In 2–3 days the child was relieved of psychotic symptoms. Hence, she was started on modified ATT without Isoniazid. The child's condition improved substantially over the next 3 days.

Keywords

Adverse effects, Isoniazid, Psychosis, Tuberculosis, Anti-psychotic